2018 annual financial data

Quince Therapeutics 2018 Net margin

Quince Therapeutics 2018 net margin with verified reported values.

Direct answer

Net margin was Not calculable.

Operating income was -12,119,000 USD and net income was -12,476,000 USD.
Operating cash flow was -11,695,000 USD.

Get free Quince Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-12,119,000 USD
Net income
-12,476,000 USD
Operating cash flow
-11,695,000 USD